131 related articles for article (PubMed ID: 2413291)
21. Diltiazem and nitrendipine suppress hypoxic contracture in quiescent ventricular myocardium.
Henry PD; Wahl AM
Eur Heart J; 1983 Nov; 4(11):819-22. PubMed ID: 6653595
[TBL] [Abstract][Full Text] [Related]
22. Effects of calcium-antagonistic coronary vasodilators, nifedipine and verapamil, on ventricular automaticity of the dog.
Endoh M; Yanagisawa T; Taira N
Naunyn Schmiedebergs Arch Pharmacol; 1978 Apr; 302(2):235-8. PubMed ID: 652065
[TBL] [Abstract][Full Text] [Related]
23. Inotropic and electrophysiological effects of PY 108-068 on isolated cardiac preparations.
Tejerina MT; Delgado C; Diez J; Tamargo J
Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):64-80. PubMed ID: 6497511
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular effects of FR34235, a new dihydropyridine slow channel blocker, in isolated rabbit myocardium and aorta.
Furuta T; Shibata S; Kodama I; Yamada K
J Cardiovasc Pharmacol; 1983; 5(5):836-41. PubMed ID: 6195473
[TBL] [Abstract][Full Text] [Related]
25. Vascular versus myocardial selectivity of calcium antagonists studied by concentration-time-effect relations.
Ljung B; Kjellstedt A; Orebäck B
J Cardiovasc Pharmacol; 1987; 10 Suppl 1():S34-9. PubMed ID: 2442515
[TBL] [Abstract][Full Text] [Related]
26. Functional interaction between local anaesthetics and calcium antagonists in guineapig myocardium: 1. Cardiodepressant effects in isolated organs.
Herzig S; Ruhnke L; Wulf H
Br J Anaesth; 1994 Sep; 73(3):357-63. PubMed ID: 7946864
[TBL] [Abstract][Full Text] [Related]
27. Comparison of negative inotropic potency, reversibility, and effects on calcium influx of six calcium channel antagonists in cultured myocardial cells.
Barry WH; Horowitz JD; Smith TW
Br J Pharmacol; 1985 May; 85(1):51-9. PubMed ID: 4027472
[TBL] [Abstract][Full Text] [Related]
28. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
Polster P; Christophe B; Van Damme M; Houlliche A; Chatelain P
J Pharmacol Exp Ther; 1990 Nov; 255(2):593-9. PubMed ID: 1700816
[TBL] [Abstract][Full Text] [Related]
29. Differential potentiation by depolarization of the effects of calcium antagonists on contraction and Ca2+ current in guinea-pig heart.
Okuyama R; Adachi-Akahane S; Nagao T
Br J Pharmacol; 1994 Oct; 113(2):451-6. PubMed ID: 7834195
[TBL] [Abstract][Full Text] [Related]
30. Inotropic effects of calcium antagonists in the cardiomyopathic Syrian hamster.
Finkel MS; Romeo RC; Oddis CV; Salama G
J Cardiovasc Pharmacol; 1992 Apr; 19(4):546-53. PubMed ID: 1380597
[TBL] [Abstract][Full Text] [Related]
31. Negative inotropic activity of the calcium antagonists isradipine, nifedipine, diltiazem, and verapamil in diseased human myocardium.
Schwinger RH; Böhm M; Erdmann E
Am J Hypertens; 1991 Feb; 4(2 Pt 2):185S-187S. PubMed ID: 1827017
[TBL] [Abstract][Full Text] [Related]
32. Inotropic effects of Ca2+ channel agonist and antagonists in neuraminidase-treated left atria of rats.
Hattori Y; Hazama S; Kanno M; Nakao Y
Br J Pharmacol; 1986 Feb; 87(2):299-305. PubMed ID: 2420406
[TBL] [Abstract][Full Text] [Related]
33. Species differences in the negative inotropic response of 1,4-dihydropyridine calcium channel blockers in myocardium.
Boyd RA; Giacomini JC; Giacomini KM
J Cardiovasc Pharmacol; 1988 Dec; 12(6):650-7. PubMed ID: 2467082
[TBL] [Abstract][Full Text] [Related]
34. The relative sensitization by acidosis of five calcium blockers in cat papillary muscles.
Smith HJ; Briscoe MG
J Mol Cell Cardiol; 1985 Jul; 17(7):709-16. PubMed ID: 4020884
[TBL] [Abstract][Full Text] [Related]
35. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
[TBL] [Abstract][Full Text] [Related]
36. Relationship of binding of a calcium channel blocker to inhibition of contraction in intact cultured embryonic chick ventricular cells.
Marsh JD; Loh E; Lachance D; Barry WH; Smith TW
Circ Res; 1983 Oct; 53(4):539-43. PubMed ID: 6313249
[TBL] [Abstract][Full Text] [Related]
37. Calcium antagonistic and antiarrhythmic actions of CPU-23, a substituted tetrahydroisoquinoline.
Dong H; Sheng JZ; Lee CM; Wong TM
Br J Pharmacol; 1993 May; 109(1):113-9. PubMed ID: 8495235
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of chronic calcium channel blocker treatment on the inotropic response of diabetic rat myocardium to acute ethanol exposure.
Brown RA; Sundareson AM; Lee MM; Savage AO
Life Sci; 1996; 59(10):835-47. PubMed ID: 8761317
[TBL] [Abstract][Full Text] [Related]
39. Dopamine antagonist effect of verapamil on isolated perfused rabbit ear artery.
Johnson CE; Steinsland OS; Scriabine A
J Pharmacol Exp Ther; 1983 Sep; 226(3):802-5. PubMed ID: 6136602
[TBL] [Abstract][Full Text] [Related]
40. Effects of hypoxia, elevated K+ and acidosis on the potency of verapamil, diltiazem and nifedipine in the guinea-pig isolated papillary muscle.
Robertson MJ; Lumley P
Br J Pharmacol; 1989 Nov; 98(3):937-49. PubMed ID: 2590774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
